EARLY ACHIEVEMENT OF PARTIAL MAYO SCORE REMISSION AND IBDQ NORMALIZATION IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY
Marc Ferrante 1
Brian G. Feagan 2
Chohee Yun 3
Jie Zhang 3
Laurent Peyrin-Biroulet 4
Severine Vermeire 4
Silvio Danese 5
1 Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium
2 Robarts Research Institute, Western University, London, ON, Canada
3 Gilead Sciences Inc., Foster City, CA, United States
4 Inflammatory Bowel Disease Unit, Nancy University Hospital, Nancy, France
5 IBD Center, Humanitas Research Hospital, Milan, Italy
Topic
IBD
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]